# A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma

> **NCT00001436** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 24 (—)

## Conditions studied

- Neoplasm Metastasis
- Osteosarcoma

## Interventions

- **DRUG:** OncoLAR® (Registered Trademark)
- **DRUG:** tamoxifen

## Key facts

- **NCT ID:** NCT00001436
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-05
- **Primary completion:** —
- **Final completion:** 2000-09
- **Target enrollment:** 24 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001436, "A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00001436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*